Keating Financial Advisory Services’s Sana Biotechnology SANA Stock Holding History

Keating Financial Advisory Services’s Portfolio SANA Stock Details SANA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3	Buy	+1	New	+$3	﹤0.01%	2605

Other funds holding SANA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Marex Group London $23.6B AUM 57.16% 1-Year Est. Return

Keating Financial Advisory Services's SANA Position: Q2 2026 in Review

Keating Financial Advisory Services opened a new position in Sana Biotechnology (SANA) in Q2 2026: 1 share worth $3. The stake represents ﹤0.01% of the portfolio and ranks #2605 among its holdings.

210 funds tracked by Wall St. Rank hold SANA as of Q2 2026.

Keating Financial Advisory Services held 1 share of Sana Biotechnology worth $3 as of Q2 2026.
Sana Biotechnology was a new Keating Financial Advisory Services position in Q2 2026.
Sana Biotechnology made up ﹤0.01% of Keating Financial Advisory Services's portfolio in Q2 2026, its #2605 holding.
210 funds tracked by Wall St. Rank held Sana Biotechnology as of Q2 2026.

Based on Keating Financial Advisory Services's 13F filing for Q2 2026, filed 11 Aug 2026.